Literature DB >> 8777769

Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome.

M Demirkiran1, J Jankovic, J M Dean.   

Abstract

3,4-Methylenedioxymethamphetamine (MDMA), also known as "ecstasy" is a popular recreational drug with potential for abuse. Although its neurotoxic effects have been established in animal studies, the acute and long-term effects of this serotonergic agent in humans are still unknown. We describe a 19-year-old woman with overlapping symptoms of neuroleptic malignant syndrome and serotonin syndrome after a single exposure to MDMA. We also review 15 other cases reported in the literature to draw attention to the serious neurotoxicity, including fatal outcomes, caused by the use of this increasingly popular, illicit drug.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8777769     DOI: 10.1097/00002826-199619020-00004

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  11 in total

Review 1.  Differential diagnosis of common tremor syndromes.

Authors:  R Bhidayasiri
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

Review 2.  Substance of abuse and movement disorders: complex interactions and comorbidities.

Authors:  Andres Deik; Rachel Saunders-Pullman; Marta San Luciano
Journal:  Curr Drug Abuse Rev       Date:  2012-09

Review 3.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 4.  Clinical management of neuroleptic malignant syndrome.

Authors:  V L Susman
Journal:  Psychiatr Q       Date:  2001

Review 5.  The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.

Authors:  Edward M Mills; Daniel E Rusyniak; Jon E Sprague
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

Review 6.  Nephrotoxic effects of designer drugs: synthetic is not better!

Authors:  Randy L Luciano; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2014-03-25       Impact factor: 28.314

7.  Illicit stimulant use in humans is associated with a long-term increase in tremor.

Authors:  Stanley C Flavel; Jenna D Koch; Jason M White; Gabrielle Todd
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

8.  Overlapping of Serotonin Syndrome with Neuroleptic Malignant Syndrome due to Linezolid-Fluoxetine and Olanzapine-Metoclopramide Interactions: A Case Report of Two Serious Adverse Drug Effects Caused by Medication Reconciliation Failure on Hospital Admission.

Authors:  Faizan Mazhar; Shahzad Akram; Nafis Haider; Rafeeque Ahmed
Journal:  Case Rep Med       Date:  2016-06-28

9.  Symptomatological features of patients with and without Ecstasy use during their first psychotic episode.

Authors:  Fabio Rugani; Silvia Bacciardi; Luca Rovai; Matteo Pacini; Angelo Giovanni Icro Maremmani; Joseph Deltito; Liliana Dell'osso; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2012-06-27       Impact factor: 3.390

10.  Olanzepine-induced neuroleptic malignant syndrome in a case of multiple sclerosis.

Authors:  Deepak Hanumanthaiah; Kumar Ramanathan
Journal:  Indian J Crit Care Med       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.